Dr. Ju Dong Yang has completed fellowships in gastroenterology, hepatology, and transplant hepatology. He holds a master’s degree in clinical and translational research from the Mayo Clinic. He is a liver cancer clinician and researcher who studies epidemiology, health disparities and outcomes, and biomarkers. His work focuses on the early detection of liver cancer. As a medical director of the Liver Cancer Program at Cedars-Sinai Cancer Center, he addresses liver cancer and non-alcoholic fatty liver disease in high-risk populations. His research program has been focused on the clinical and translational research of liver cancer. He has been interested in liver cancer health disparities research from a global perspective and liver cancer biomarker research.